The Pharmacogenomics Journal - Issue - nature.com science feeds

Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review

D F Carr — 2009-09-22

Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review

The Pharmacogenomics Journal 9, 291 (October 2009). doi:10.1038/tpj.2009.29

Authors: D F Carr, G Whiteley, A Alfirevic & M Pirmohamed

Prevalence of CYP2C9 polymorphisms in the south of Europe

Paula Sánchez-Diz — 2009-09-22

Prevalence of CYP2C9 polymorphisms in the south of Europe

The Pharmacogenomics Journal 9, 306 (October 2009). doi:10.1038/tpj.2009.16

Authors: Paula Sánchez-Diz, Ana Estany-Gestal, Carmelo Aguirre, Adoración Blanco, Angel Carracedo, Luisa Ibáñez, Marianna Passiu, Lisa Provezza, Ricardo Ramos-Ruiz, Borja Ruiz, Inés Salado-Valdivieso, Eladio A Velasco & Adolfo Figueiras

Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia

B A Fijal — 2009-09-22

Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia

The Pharmacogenomics Journal 9, 311 (October 2009). doi:10.1038/tpj.2009.24

Authors: B A Fijal, B J Kinon, S Kapur, V L Stauffer, R R Conley, H H Jamal, J M Kane, M M Witte & J P Houston

Association of genotypes of the CYP3A cluster with midazolam disposition in vivo

J Miao — 2009-09-22

Association of genotypes of the CYP3A cluster with midazolam disposition in vivo

The Pharmacogenomics Journal 9, 319 (October 2009). doi:10.1038/tpj.2009.21

Authors: J Miao, Y Jin, R L Marunde, S Kim, S Quinney, M Radovich, L Li & S D Hall

Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52 000 individuals

D Kaur-Knudsen — 2009-09-22

Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52 000 individuals

The Pharmacogenomics Journal 9, 327 (October 2009). doi:10.1038/tpj.2009.34

Authors: D Kaur-Knudsen, S E Bojesen & B G Nordestgaard

Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors

H Landmark-Høyvik — 2009-09-22

Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors

The Pharmacogenomics Journal 9, 333 (October 2009). doi:10.1038/tpj.2009.27

Authors: H Landmark-Høyvik, K V Reinertsen, J H Loge, S D Fosså, A L Børresen-Dale & V Dumeaux

Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility

A L Teixeira — 2009-09-22

Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility

The Pharmacogenomics Journal 9, 341 (October 2009). doi:10.1038/tpj.2009.20

Authors: A L Teixeira, R Ribeiro, A Morais, F Lobo, A Fraga, F Pina, F M Calais-da-Silva, F E Calais-da-Silva & R Medeiros

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients

D Caronia — 2009-09-22

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients

The Pharmacogenomics Journal 9, 347 (October 2009). doi:10.1038/tpj.2009.19

Authors: D Caronia, A Patiño-García, R L Milne, M Zalacain-Díez, G Pita, M R Alonso, L T Moreno, L Sierrasesumaga-Ariznabarreta, J Benítez & A González-Neira